Table 1. Summary of clinical data of study participants.
Characteristic | Median (Range) | ||||
Age (Years) | 28 (22–47) | ||||
Plasma HIV RNA (Copies/ml) | 11000 (200−260000) | ||||
CD4 Count (cells/µl) | 492 (295–1437) | ||||
Frequency of HIV-specific T-cell responses | CDu422 | CCH | B | A | D |
N (%) | 36 (92) | 35 (90) | 27 (69) | 30 (77) | 34 (87) |
N (number of participants) = 40. N = 39 participants were screened for immunological responses and 36 had responses to at least one Gag peptide. CDu422: South African clade C, CCH: Chinese clade C; A, B and D are clades A, B, and D sequences.